Numerous epidemiological studies link bone loss with vascular calcification and cardiovascular disease. Osteoporosis and atherosclerosis share risk factors and are likely to share pathogenic mechanisms as well. On the other hand, drugs used in the treatment of osteoporosis could influence cardiovascular risk, just as those used in cardiovascular disease could affect bone mineral density and the development of fractures.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.medcli.2024.07.004 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!